Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death

NCT04914832 is registered in ClinicalTrials.gov with Shabir Madhi as lead sponsor.

NCT NCT04914832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04914832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death
Lead sponsor
Shabir Madhi
Phase
Phase 4
Overall status
Completed
Start date
August 30, 2021
Completion date
September 30, 2022
Enrollment
75,012 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, pneumonia, viral